Skip Navigation


ToxSci Advance Access originally published online on August 19, 2004
Toxicological Sciences 2004 82(1):70-79; doi:10.1093/toxsci/kfh257
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
82/1/70    most recent
kfh257v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (24)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sanderson, J. T.
Right arrow Articles by van den Berg, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanderson, J. T.
Right arrow Articles by van den Berg, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences vol. 82 no. 1 © Society of Toxicology 2004; all rights reserved.

Induction and Inhibition of Aromatase (CYP19) Activity by Natural and Synthetic Flavonoid Compounds in H295R Human Adrenocortical Carcinoma Cells

J. Thomas Sanderson*,1, Joost Hordijk*, Michael S. Denison{dagger}, Mark F. Springsteel{ddagger}, Michael H. Nantz{ddagger} and Martin van den Berg*

* Institute for Risk Assessment Sciences (IRAS), Utrecht University, 3508 TD, Utrecht, The Netherlands; {dagger} Department of Environmental Toxicology, and {ddagger} Department of Chemistry, University of California, Davis, California 95616

Received June 2, 2004; accepted August 9, 2004

Flavonoids and related structures (e.g., flavones, isoflavones, flavanones, catechins) exert various biological effects, including anticarcinogenic, antioxidant and (anti-)estrogenic effects, and modulation of sex hormone homeostasis. A key enzyme in the synthesis of estrogens from androgens is aromatase (cytochrome P450 19; CYP19). We investigated the effects of various natural and synthetic flavonoids on the catalytic activity and promoter-specific expression of aromatase in H295R human adrenocortical carcinoma cells. Natural flavones were consistently more potent inhibitors than flavanones. IC50 values for 7-hydroxyflavone, chrysin, and apigenin were 4, 7, and 20 µM, respectively; for the flavanones 7-hydroxyflavanone and naringenin the IC50 values were 65 and 85 µM, respectively. The steroidal aromatase inhibitor (positive control) 4-hydroxyandrostenedione had an IC50 of 20 nM. The inhibition by apigenin and naringenin coincided with some degree of cytotoxicity at 100 µM. The natural flavonoid derivative rotenone (IC50 0.3 µM) was the most potent aromatase inhibitor tested. Several synthetic flavonoid and structurally related quinolin-4-one analogs inhibited aromatase activity. The most potent inhibitor was 4'-tert-butyl-quinolin-4-one (IC50 2 µM), followed by two 2-pyridinyl-substituted alpha-naphthoflavones (IC50s 5 and >30 µM). The two 2-pyridinyl-substituted gamma-naphthoflavones consistently produced biphasic concentration-response curves, causing about 1.5-fold aromatase induction at concentrations below 1 µM and inhibition above that level (IC50s 7 and >30 µM). The natural flavone quercetin and isoflavone genistein induced aromatase activity 4- and 2.5-fold induction, respectively, at 10 µM. This coincided with increased intracellular cAMP concentrations and increased levels of the cAMP-dependent pII and to a lesser extent 1.3 promoter-specific aromatase transcripts. These results shed light on the structure–activity relationships for aromatase inhibition as well as mechanisms of induction in human H295R cells.

Key Words: H295R; flavonoids; quinolin-4-ones; catechins; aromatase; endocrine disruption; induction; inhibition; transcription.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
S. Rice and S. A Whitehead
Phytoestrogens and breast cancer -promoters or protectors?
Endocr. Relat. Cancer, December 1, 2006; 13(4): 995 - 1015.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
Y. HONG and S. CHEN
Aromatase Inhibitors: Structural Features and Biochemical Characterization
Ann. N.Y. Acad. Sci., November 1, 2006; 1089(1): 237 - 251.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. T. Sanderson
The Steroid Hormone Biosynthesis Pathway as a Target for Endocrine-Disrupting Chemicals
Toxicol. Sci., November 1, 2006; 94(1): 3 - 21.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. J. Auborn
Can Indole-3-Carbinol-Induced Changes in Cervical Intraepithelial Neoplasia Be Extrapolated to Other Food Components?
J. Nutr., October 1, 2006; 136(10): 2676S - 2678S.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.